New CKM guideline urges team-based care, yet UH data show major therapy gaps; CINEMA model boosts outcomes amid cost, trust, and handoff hurdles.
|Articles|December 1, 2000
Supplements and Featured Publications
- New Approaches for the Diagnosis and Management of Alzheimer's Disease
- Volume 6
- Issue 22 Suppl
Introduction
Advertisement
Articles in this issue
almost 26 years ago
Participating Facultyalmost 26 years ago
Screening and Early Diagnosis of Dementiaalmost 26 years ago
Alzheimer's Disease: Clinical Treatment Optionsalmost 26 years ago
The Pharmacoeconomics of Alzheimer's Diseasealmost 26 years ago
Managed Care Decisions in Alzheimer's Diseasealmost 26 years ago
Continuing Medical Education Quizalmost 26 years ago
Selected AbstractsAdvertisement
Related to this article
Obesity care surges with GLP-1 demand, but fragmented ownership, prior authorizations, and coverage rules stall treatment—pharmacists step in.
Roundtables reveal HFpEF/HFmrEF care lags despite rising cases; learn new SGLT2/MRA strategies, screening, and scalable team pathways.
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves First Treatment for Sanfilippo Syndrome Type A
2
No Blood Biomarker Is Ready to Pick Psoriasis Therapy
3
Regorafenib Prescribing in Advanced GIST Deviates From Guidelines
4
Oral GLP-1s, Medicare Bridge Reshape Obesity Care: Holly Lofton, MD
5